Browsing Tag
Xywav
2 posts
Jazz Pharmaceuticals closes $820m Actio Biosciences deal to deepen epilepsy pipeline
Jazz Pharmaceuticals buys Actio Biosciences for $820 million upfront, betting on ABS-1230 while early-stage clinical risk remains the key test.
Lupin secures tentative FDA approval for Xywav oral solution generic
Global pharma leader, Lupin Limited, proudly announced its tentative approval from the United States Food and Drug Administration…